Goldstein David M — SEC insider filings
SEC reporting owner CIK 1751719. 8 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2020-08-12 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 9,225 shares, $604,223 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 2,534 shares @ $88.40 ($224,012) in Principia Biopharma Inc., filed 2020-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Principia Biopharma Inc. (PRNB) | Chief Scientific Officer | 2 | — | 6 legs · 6,000 sh · $531,665 | 14 |
| ALUMIS INC. (ALMS) | Chief Scientific Officer | 6 | — | 2 legs · 3,225 sh · $72,558 | 20 |
Insider filings — Goldstein David M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | ALUMIS INC. (ALMS) | Sale (S): 629 @ $6.52 | EDGAR |
| 2026-08-05 | 4 | ALUMIS INC. (ALMS) | Sale (S): 2,596 @ $26.37 | EDGAR |
| 2026-01-28 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 216,675 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 27,000 @ $0 · Grant/award (A): 107,950 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | ALUMIS INC. (ALMS) | Disposition to issuer (D): 213,903 · Grant/award (A): 213,903 · Disposition to issuer (D): 2,994 · Grant/award (A): 2,994 · Disposition to issuer (D): 42,780 (derivative) @ $0 · Grant/award (A): 42,780 (derivative) @ $0 · +10 more | EDGAR |
| 2020-09-28 | 4 | Principia Biopharma Inc. (PRNB) | Code (U): 31,826 @ $100 · Disposition to issuer (D): 12,960 (derivative) · Disposition to issuer (D): 13,210 (derivative) · Disposition to issuer (D): 8,807 (derivative) · Disposition to issuer (D): 15,412 (derivative) · Disposition to issuer (D): 22,017 (derivative) · +4 more | EDGAR |
| 2020-08-12 | 4 | Principia Biopharma Inc. (PRNB) | Option exercise (M): 2,447 @ $3.00 · Option exercise (M): 3,553 @ $3.18 · Sale (S): 858 @ $86.11 · Sale (S): 700 @ $86.92 · Sale (S): 2,534 @ $88.40 · Sale (S): 700 @ $89.68 · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1751719 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs